Journal Basic Info
- Impact Factor: 1.809**
- H-Index: 6
- ISSN: 2474-1655
- DOI: 10.25107/2474-1655
Major Scope
- Endocrinology
- Vascular Medicine
- Physiology
- Nuclear Medicine
- Hematology
- Hepatology
- Women’s Health Care
- Obstetrics and Gynecology
Abstract
Citation: Ann Clin Case Rep. 2024;9(1):2567.DOI: 10.25107/2474-1655.2567
Analysis of Major Project Management Problems in the Research and Development of New Biological Products in China
Song X, Gao M, Li X, Wang Y and Hu Y*
Beijing Engineering Research Center of Protein and Antibody, Sinocelltech Ltd., China
PDF Full Text Review Article | Open Access
Abstract:
At present, Chinese biomedical enterprises are rapidly developing to product innovation, enterprise scale expanding, management regularization and Research and Development (R&D) cycle shortened, which indicates that most enterprises who cannot quickly complete the transformation to adapt to the development trend of biomedical development, especially small and medium-sized enterprises, will face the risk of being eliminated. In order to solve these difficulties, a scientific and effective new biological products R&D project management system should be established, in addition to the need for continuous scientific innovation and technological upgrading. The general process of new biological products R&D in China as the starting point, the author fully analyzed the main problems of R&D project management of new biological products in this paper. It is proposed that biomedical enterprises should not only solve the problems of project process management in project initiation, planning, execution and changes, abort and closure, but also solve the problems in project enterprise management environment such as human resource allocation, project communication management and performance appraisal. It is suggested that on the basis of fully analyzing the overall R&D process, segmented project management is implemented to establish a scientific and effective project management system based on "systematic management". What the enterprise decision makers need to weigh is that when to start and how much to cost to establish a scientific and standardized R&D project management system, and complete enterprise management upgrading. Transformation is painful, but also imperative.
Keywords:
Project Management; General Process of R&D of New Biological Products; Major Project Management Problems
Cite the Article:
Song X, Gao M, Li X, Wang Y, Hu Y. Analysis of Major Project Management Problems in the Research and Development of New Biological Products in China. Ann Clin Case Rep. 2024; 9: 2567..